Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine's greatest challenges. GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com . As the Policy and Reimbursement Lead reporting to the Vice President of Government Affairs, Policy & Alliance Development and working closely with highly collaborative teammates, you will be instrumental in shaping both internal and external strategies related to broad access policy and specific public payer engagements / policy initiatives. Your role will directly contribute to the timely accessibility of our innovative multi-cancer early detection test and pipeline products through effective coverage and reimbursement frameworks. You will work on-site full-time at our office located in Washington DC.